Primary Sclerosing Cholangitis

PSC should be considered with a cholestatic biochemical pattern, including elevated alkaline phosphatase, gamma-glutamyltransferase, or bilirubin, with or without symptoms. The defining clinical framework combines cholestatic liver biochemistry with multifocal biliary stricturing on cholangiography. ScienceDirect+1ScienceDirectPrimary sclerosing cholangitis – a comprehensive reviewaasldPrimary Sclerosing Cholangitis Management Tips and Tricks

MRCP is generally the first cholangiographic study because it noninvasively evaluates intrahepatic and extrahepatic ducts, including ducts proximal to severe stenoses. Reported MRCP sensitivity and specificity for PSC are 85% to 88% and 92% to 97%, respectively; subtle early disease can be missed, and cirrhosis can distort ducts and mimic PSC. ScienceDirectScienceDirectPrimary Sclerosing Cholangitis - an overview

ERCP is not a routine diagnostic substitute for MRCP because it is invasive, but it is appropriate when MRCP is nondiagnostic despite persistent clinical suspicion or when a stricture requires endoscopic assessment or therapy. ERCP also enables tissue-directed evaluation when malignancy is a concern. ScienceDirectScienceDirectPrimary Sclerosing Cholangitis - an overview

PSC is a chronic fibroinflammatory cholangiopathy that can progress to biliary cirrhosis, portal-hypertensive complications, and liver failure. A review of PSC natural history reported median transplant-free survival of approximately 15 years, although individual trajectories vary substantially. PubMedPubMedPrimary sclerosing cholangitis: A review and update

Cholangiocarcinoma is a defining competing risk. Published estimates in the supplied literature place lifetime cholangiocarcinoma risk at approximately 10% to 15%, although broader estimates of 9% to 31% have also been reported. ScienceDirect+1ScienceDirectSurgical Treatment of Primary Sclerosing CholangitisScienceDirectPrimary Sclerosing Cholangitis - an overview This variation underscores uncertainty in counseling an individual patient, but supports a low threshold to investigate a new obstructive or constitutional change.

Gallbladder cancer risk is also increased. Reported prevalence estimates range from 2.5% to 3.5%, with substantially higher estimates in some series; prognosis after gallbladder cancer diagnosis is poor. aasldaasldWhy do people with primary sclerosing cholangitis require ...

Effective pharmacotherapy for PSC has not been established, and current educational reviews emphasize that no medical therapy has been shown to alter disease progression. Therefore, treatment should be directed at symptoms, bacterial cholangitis, biliary obstruction, portal-hypertensive and cirrhotic complications, nutritional consequences of cholestasis when present, and transplant candidacy. PubMed+2PubMedPrimary sclerosing cholangitis: A review and updatePubMedPrimary Sclerosing Cholangitis - StatPearls - NCBI BookshelfaasldPrimary Sclerosing Cholangitis Management Tips and Tricks

Endoscopic intervention is most relevant when a clinically significant biliary stricture is suspected because of worsening cholestasis, jaundice, pruritus, cholangitis, or concern for malignancy. ERCP can define the lesion, facilitate directed diagnostic assessment, and permit nonoperative dilation of dominant strictures. ScienceDirect+1ScienceDirectPrimary Sclerosing Cholangitis - an overviewaasldAASLD PRACTICE GUIDELINES Diagnosis and Management ...

Refer patients with advanced disease to a transplant center before a crisis-driven evaluation. In addition to decompensated cirrhosis, recognized PSC-specific reasons to consider transplantation include recurrent bacterial cholangitis, intractable pruritus, severe jaundice, and high-grade biliary dysplasia. PubMed+1PubMedPrimary Sclerosing Cholangitis: Diagnosis, Management, and ...aasldPrimary Sclerosing Cholangitis Management Tips and Tricks

Surveillance is justified by the substantial risk of cholangiocarcinoma and increased gallbladder cancer risk, but the supplied sources do not provide a single U.S. society-endorsed interval or a fully specified surveillance protocol. MRI/MRCP is central to evaluating concerning strictures or masses, and CA 19-9 is best interpreted as an adjunct because isolated elevation lacks sufficient specificity. aasldaasldWhy do people with primary sclerosing cholangitis require ...

Colonoscopy at PSC diagnosis is important to identify occult IBD. Continued colorectal cancer prevention should then be coordinated with gastroenterology using the patient’s IBD phenotype and current guideline-based surveillance plan; exact U.S. surveillance intervals are not supplied in the source set. aasldaasldPrimary Sclerosing Cholangitis Management Tips and Tricks

At each follow-up, reassess for symptoms that indicate obstruction, infection, cancer, or hepatic decompensation: jaundice, escalating pruritus, fever or recurrent cholangitis, abdominal pain, weight loss, ascites, variceal bleeding, or encephalopathy. These changes should prompt expedited diagnostic reassessment rather than routine observation. ScienceDirect+3ScienceDirectPrimary sclerosing cholangitis – a comprehensive reviewPubMedPrimary Sclerosing Cholangitis: Diagnosis, Management, and ...aasldPrimary Sclerosing Cholangitis Management Tips and TricksaasldWhy do people with primary sclerosing cholangitis require ...